Prevalence of Ras mutations in thyroid neoplasia

Clinical Endocrinology

Volumn 50, Issue 4, 1999, Pages 529-535

  Esapa, Christopher T ^a   Johnson, Sarah J ^b   Kendall Taylor, Pat ^b   Lennard, Tom W J ^b   Harris, Philip E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANAPLASTIC CARCINOMA; ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; METASTASIS; NODULAR GOITER; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RAS; PREVALENCE; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ALLELES; CARCINOMA; CARCINOMA, PAPILLARY, FOLLICULAR; CODON; GENES, RAS; GOITER, NODULAR; HUMANS; IN SITU HYBRIDIZATION; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREVALENCE; THYROID NEOPLASMS;

EID: 0008212049     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00704.x     Document Type: Article

References (23)

1. Andersen, N.G., Maller, J.L., Tonks, N.K. & Sturgill, T.W. (1990) Requirements for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature, 343, 651-653.
2. Bond, J.A., Wyllie, F.S., Rowson, J., Radulescu, A. & Wynford-Thomas, D. (1994) In vitro reconstruction of tumour initiation in a human epithelium. Oncogene, 9, 281-290.
3. Bos, J.L. (1989) Ras oncogenes in human cancer: a review. Cancer Research, 49, 4682-4689.
4. Bouras, M., Bertholon, J., Dutrieux-Berger, N., Parvaz, P., Paulin, C., Revol, A. (1998) Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers. European Journal of Endocrinology, 139, 209-216.
5. Challeton, C., Bounacer, A., Du-Villard, J.A., Caillou, B., De-Vathaire, F., Monier, R., Schlumberger, M., Suarez, H.G. (1995) Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors. Oncogene, 11, 601-603.
6. Chiappetta, G., Fabien, N., Picone, A., Califano, D., Monaco, C., de-Franciscis, V., Vecchio, G., Santelli, G. (1996) Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization. Oncology Research, 8, 85-93.
7. Cook, S., McCormick, F. (1994) Ras blooms on sterile ground. Nature, 369, 418-420.
8. Davis, R.J. (1993) The mitogen-activated protein kinase signal transduction pathway. Journal of Biological Chemistry, 268, 14553-14556.
9. Esapa, C., Foster, S., Johnson, S., Jameson, J.L., Kendall-Taylor, P., Harris, P.E. (1997) G protein and thyrotropin receptor mutations in thyroid neoplasia. Journal of Clinical Endocrinology and Metabolism, 82, 493-496.
10. Ezzat, S., Zheng, L., Kolenda, J., Safarian, A., Freeman, J.L., Asa, S.L. (1996) Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid, 6, 409-416.
11. Faure, M., Voyno-Yasenetskaya, T.A., Bourne, H.R. (1994) cAMP and bg subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. Journal of Biological Chemistry, 269, 7851-7854.
12. Hara, H., Fulton, N., Yashiro, T., Ito, K., DeGroot, L.J., Kaplan, E.L. (1994) N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery, 116, 1010-1016.
13. Harris, P.E., Alexander, J.M., Bikkal, H.A., Hsu, D.W., Hedley-Whyte, E.T., Klibanski, A., Jameson, J.L. (1992) Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations. Journal of Clinical Endocrinology and Metabolism, 75, 918-923.
14. Lemoine, N.R., Mayall, E.S., Wyllie, F.S., Williams, E.D., Goyns, M., Stringer, B., Wynford-Thomas, D. (1989) High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene, 4, 159-164.
15. Manenti, G., Pilotti, S., Re, F.C., Della-Porta, G., Pierotti, M.A. (1994) Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. European Journal of Cancer, 30A, 987-993.
16. Namba, H., Rubin, S.A., Fagin, J.A. (1990) Point mutations of ras oncogenes are early event in thyroid tumorigenesis. Molecular Endocrinology, 4, 1474-1479.
17. Polak, M. (1998) Activating mutations of the thyrotropin receptor: a short review with emphasis on some pediatric aspects. European Journal of Endocrinology, 138, 353-357.
18. Rochefort, P., Caillou, B., Michiels, F.M., Ledent, C., Talbot, M., Schlumberger, M., Lavelle, F., Monier, R., Feunteun, J. (1996) Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene, 12, 111-118.
19. Said, S., Schlumberger, M., Suarez, H.G. (1994) Oncogenes and anti-oncogenes in human epithelial thyroid tumors. Journal of Endocrinological Investigation, 17, 371-379.
20. Salvatore, D., Celetti, A., Fabien, N., Paulin, C., Martelli, M.L., Battaglia, C., Califano, D., Monaco, C., Viglietto, G., Santoro, M., Fusco, A. (1996) Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours. European Journal of Endocrinology, 134, 177-183.
21. Shi, Y., Zou, M., Schmidt, H., Juhasz, F., Stensky, V., Robb, D., Farid, N.R. ( 1991 ) High rates of ras codon 61 mutations in thyroid tumors in an iodide-deficient area. Cancer Research, 51, 2690-2693.
22. Taparowsky, E., Suard, Y., Fasano, O., Shimizu, K., Goldfarb, M., Wigler, M. (1982) Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature, 300, 762-765.
23. Wynford-Thomas, D. (1995) Molecular genetics of thyroid cancer. Current Opinion in Endocrinology and Diabetes, 2, 429-436.